Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 387,881 | 300,421 | 206,831 | 169,598 | 87,630 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $387,881K)
= 0.00
The debt-to-capital ratio for Catalyst Pharmaceuticals Inc has remained consistently at 0.00 over the past five years, including as of December 31, 2023. This indicates that the company has not utilized any debt in its capital structure during this period. A debt-to-capital ratio of 0.00 suggests that the company has solely relied on equity financing to fund its operations and investments. It reflects a low financial risk associated with debt obligations and portrays a strong financial position in terms of leverage. Investors may view such a ratio positively as it signifies financial stability and the absence of debt-related concerns in the company's operations. Nonetheless, it is essential to consider other financial metrics and factors to assess the company's overall financial health comprehensively.
Peer comparison
Dec 31, 2023